Cancer of the Vulva. Essentials of Diagnosis Typically occurs in postmenopausal women. Long history of vulvar irritation with pruritus, local discomfort,

Slides:



Advertisements
Similar presentations
PROF OF OB &GYN. AIN SHAMS UNIVERSITY,GYNEONCOLOGY UNIT.
Advertisements

Endometrial Cancer May 2007 Dr Anna Winship Guy’s & St. Thomas’ NHS Trust Click Here For First Question Oncology Registrars’ Forum “Best of Five”
MALIGNANT OVARIAN TUMOUR
CANCER OF THE VAGINA Dr Samar Sarsam
Female Genitalia IV Ovary. l Inflammation l Non-neoplastic cysts l Neoplasms.
Pelvic Masses & Ovarian Cancer. Differential diagnosis of pelvic masses Investigations and management Benign ovarian cysts Ovarian cancer.
Epidemiology of Gynaecological Cancers. General Overview On global basis cervical cancer is the most common pelvic malignancy in developing countries.
Endometrial Cancer Tseng Jen-Yu 02/05/2007 Tseng Jen-Yu 02/05/2007.
Malignant disease of the cervix
Carcinoma of the Vulva.
ONCOLOGY OF VULVA AND VAGINA
A significant increase in the incidence of endometrial cancer. This increased incidence of endometrial cancer has been widely interpreted to be a result.
District 1 ACOG Medical Student Teaching Module 2009
Carcinoma of the Endometrium1 CARCINOMA OF THE ENDOMETRIUM Wen Di, M.D. , Ph.D.
Xi-Shi Liu Obstetrics and Gynecology Hospital Fudan university
Malignant Disease Of The Uterus Dr Khalid Sait FRCSC A.Professor of Gynecological Oncology KAAUH, Jeddah( KSA)
Malignant Ovarian Tumors
CARCINOMA OF THE ENDOMETRIUM
Ovary.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Endometrial Cancer ASSOCIATE PROFESSOR Iolanda Blidaru MD, PhD.
Malignant disease of the body of the uterus  The most common malignant diseas affecting the uterus is endometrial carcinoma, which arises from the lining.
INVASIVE CANCER of THE VULVA
Vulvar and Vaginal lesions
Cervical Cancer. Cervix Lower part of the uterus Lower part of the uterus Connects the body of the uterus to the vagina (birth canal) Connects the body.
Endometrial Carcinoma Fuat Demirkıran, MD Istanbul University, Cerrahpaşa School Of Medicine, OB&GYN Department, Gyn Oncology.
Christopher R. Graber, MD Salina Women’s Clinic 08 March 2011.
Vulvar Cancer A. Gari MD..
Malignant disease of vulva Prepared by: Mrs Raheegeh Awni 12/02/2011
Department of pathology Prof:- Adiga. Student name :- Saeed Ayed saed Abdulrahman Awagi Alnami Muhannad Ali Asiri Faris.
FEMALE GENITAL SYSTEM PREMED H&P.
Fallopian Tube and Ovarian Malignancy Schwartz's Principles of Surgery Chapter 41. Gynecology.
BY DR. KHANSA IQBAL SENIOR REGISTRAR GYNAE UNIT-II.
Computed tomography scan of the abdomen shows a large cystic mass in the abdomen and pelvis without solid tissue or septations (measurement: 43×20×31-cm.
The Management of Cervical , Vulvar and Vaginal Cancers
In the name of God Isfahan medical school Shahnaz Aram MD.
Endometrial Carcinoma
Are there benefits from chemotherapy to early endometrial cancer
Ovarian cancer Karima salama.
Ovarian Tumors.
Endometrial Cancer By Jessica Hall. Symptoms Unusual vaginal bleeding or discharge Difficult or painful urination Pain during intercourse Pain in the.
By: Maureen Jaminal BIOL 316
Uterine Cancers A. Alobaid, MBBS, FRCS(C), FACOG Consultant, Gynecologic Oncology Assistant professor, KSU Medical Director, Women’s Specialized Hospital.
Tumours of the testis 1. Introduction ❏ any solid testicular mass in young patient – must rule out malignancy ❏ slightly more common in right testis (corresponds.
Dr. Saadeh Jaber OBGYN consultant Epidemiology Second most common gynecological cancer. >35, median 70 It accounts for deaths more than cancer of.
Vulvar Cancer Women’s Hospital,School of Medicine Zhejiang University.
REVISED FIGO STAGING SYSTEMS FOR GYNAECOLOGICAL CANCERS (2009) Glenn McCluggage, Belfast Trust.
Ovarian Cancers In Pregnancy. Incidence Effect on Pregnancy Histologic Variations Clinical Variation Ovarian Cancers in Pregnancy.
Ovarian Tumors Epidemiology - Ranks below only carcinoma of the cervix and the endometrium. -Ovarian cancer accounts for 6% of all cancers in the female.
Malignant & Pre-malignant Diseases of the Endometrium Jose B Moran MD Assistant Professor III Section of Gynecologic Oncology Department of Obstetrics.
KARIMA SALAMA ENDOMETRIAL CANCER. Epidemiology Most common gynecological cancer in the developed countries, with an incidence of 12.9 per 100,000 women.
Endometrial polyp, hyperplasia, carcinoma Dr: Salah Ahmed.
VULVA.
Rahimullah Khattak Final Year MBBS  Anatomy of the Ovary  Classification  Incidence  Risk Factors  Spread and Screening  Signs and Symptoms 
Mark Browning, M.D. IUSME.  22,000 Cases  14,000 Deaths  Overall Survival Rate is 35%  Survival Rate Depends on Stage.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Metastatic Tumors of Ovary. METASTATIC TUMOR FROM BREAST CANCER both ovaries replaced by pale, rather nodular tumor, with breast cancer cells arranged.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Carcinoma Vulva & Vagina
M.D. Browning, M.D. ‘77.  Most Common Cancer of Female Reproductive System  60,000/year with 10,000 deaths  Normal Cells in the Endometrium.
Malignant disease of the body of the uterus
Malignant disease of the body of the uterus
Dr . Saadeh Jaber OBGYN consultant 2010
Malignant disease of the body of the uterus
Uterine cancer Uterine mesenchymal neoplasms
Vulvar Cancer Women’s Hospital,School of Medicine Zhejiang University.
ENDOMETRIAL CARCINOMA
Principles and Practice of Radiation Therapy
Fallopian Tube Cancer Paweł Sadłecki
Presentation transcript:

Cancer of the Vulva

Essentials of Diagnosis Typically occurs in postmenopausal women. Long history of vulvar irritation with pruritus, local discomfort, and bloody discharge. Appearance of early lesions like that of chronic vulvar dermatitis. Appearance of late lesions like that of a large cauliflower, or a hard ulcerated area in the vulva. Biopsy necessary for diagnosis.

Types of Vulvar Cancer Squamous Cell Carcinoma- most common type of tumor (85-90%) and most frequently involves the anterior half of the vulva. Malignant Melanoma- second most common vulvar cancer (5%) Carcinoma of Bartholin's Gland- most common site for vulvar adenocarcinoma Basal Cell Carcinoma- arise almost exclusively in the skin of the labia majora

Squamous Cell carcinoma 65% arises in labia majora and minora 25% percent in clitoris or perineum Appearance varies from a large, exophytic, cauliflowerlike lesion to a small ulcer crater superimposed on a dystrophic lesion of the vulvar skin primary determinant of nodal metastases is tumor size.

Malignant Melanoma Accounts for 5% of vulvar cancers most commonly arises in the labia minora and clitoris superficial spread toward the urethra and vagina nonpigmented melanoma may closely resembles squamous cell carcinoma darkly pigmented, raised lesion is a characteristic finding

All small pigmented lesions of the vulva are suspect and should be removed by excision biopsy with a 0.5- to 1-cm margin of normal skin large tumors, the diagnosis should be confirmed by a biopsy

Carcinoma of Bartholin's Gland Rare (1%) but the most common site of vulvar adenocarcinoma Most common type is squamous cell

metastasis Primarily lymphatics to the superficial inguinal lymph nodes Direct extension to vagina, urethra and anus

Treatment TOC: wide local excision with inguinal lymph node metastasis Stage I: ipsilateral lymphadenectomy Stage II and III: bilateral lymphadenectomy Late stage III and IV: radical vulvectomy, lymphadenectomy and/or chemoradiation

Cancer of the Vagina

Rare, approximately 3% of gynecologic cancers Squamuos cell(85%)>adenocarcinomas> sarcomas>melanomas. Can be ulcerative or exophytic

Essentials of Diagnosis Asymptomatic: abnormal vaginal cytology. Early: painless bleeding from ulcerated tumor. Late: bleeding, pain, weight loss, swelling.

Endometrial Cancer 3 rd most common gynecologic malignancy in the Philippines Affects mostly peri/postmenopausal women RISK FACTORS: Estrogen replacement therapy4-8x Menopause after 52 years2.4x Obesity 3x-21 to 50lbs, 10x->50lbs Nulliparity 2-3x Diabetes2.8x Feminizing ovarian tumors Polycystic ovarian syndrome Tamoxifen therapy for breast cancer >2 years

Protective factors: Ovulation Progestin therapy Combination oral contraceptives Menopause prior to 49 years Normal weight Multiparity

Etiology: unopposed estrogen exposure Clinical presentation:  Abnormal uterine bleeding (80)  Physical exam ussually unremarkable

Staging FIGO Surgical Staging of Carcinoma of the Corpus Uteri Stage I Stage Ia G123 Tumor limited to endometrium Stage Ib G123 Invasion to less than one-half the myometrium Stage Ic G123 Invasion to more than one-half the myometrium Stage II Stage IIa G123 Endocervical glandular involvement only Stage IIb G123 Cervical stromal invasion Stage III Stage IIIa G123 Tumor invades serosa and/or adnexa, and/or positive peritoneal cytology Stage IIIb G123 Vaginal metastases Stage IIIc G123 Metastases to pelvic and/or paraaortic lymph nodes Stage IV Stage IVa G123 Tumor invades bladder and/or bowel mucosa Stage IVb Distant metastases including intra-abdominal and/or inguinal lymph nodes

Treatment Primary: surgery  bilateral salpingo-oophorectomy, peritoneal washings for cytology, and removal of pelvic and periaortic lymph nodes Adjuvant Chemotherapy: for advanced stages  Doxorubicin and cisplatin

Cancer of the Ovary

Epithelial -65% Germ cell % Sex cord-6% Etiology =frequent ovulatio n Risk factors=nullipairty, decreased fertility, early and late menopause, ovulatory drugs

Clinical presentation Asymptomatic until late stage Enlarging abdomen, abdominal mass Urinary frequency, dysuria, GI complaints Metastasis to the umbilicus is known as Sister Mary Joseph Nodule

Epithelial Ovarian Cancer SEROUS- most common type MUCINOUS ENDOMETRIOID CLEAR CELL BRENNER

Management SURGERY- primary management CHEMOTHERAPY- ▫Paclitaxel-Carboplatin 6 cycles every 3-4 weeks CA-125- elevated in 80% of px with ovarian Ca -use to evaluate treatment

Germ cell Tumors 20-25% of ovarian cancers Arises from undifferentiated germ cells

Histologic Classification Dysgerminoma- most common malignant GCT Teratoma- most common GCT Endodermal sinus tumor Embryonal carcinoma Polyembryoma Choriocarcinoma Mixed forms

Serum Tumor Markers for Germ Cell Neoplasis tumorhCGAFPLDHCA-125 dysgerminoma++ Mixed germ cell tumor ++++ Embryonal Carcinoma +++ Endodermal sinus+

Clinical manifestation Tumors grow rapidly Distention of the ovarian capsule Hemorrhage Pelvic pain Pressure on rectum or bladder

Treatment Unilateral salpingo-oophorectomy Sensitive to chemotherapy- bleomycin, etoposide, cisplatin (BEC) Dysgerminomas- radiation theraPY SURVIVAL RATE(5 year): Dysgerminomas-85% Immature teratomas-70 to 80% Endodermal sinus tumors- 60 to 70%

Sex Cord-Stromal Tumors Low-grade malignancies Occur at any age Usually unilateral and do not often recur Functional tumors- produced hormones Granulosa-theca cells: large amounts of estrogens Sertoli-Leydig cells: testosterone and androgens

Granulosa-theca cell tumors Precocious puberty Menstrual irregularities Secondary ammenorrhea Post-menopausal bleeding Endometrial hyperplasia and/or endometrial cancer

Sertoli-Leydig Cell tumors Virilization: breast atrophy, hirsutism, deepened voice, acne, clitoromegaly and receding hairline Oligomenorrhea or amenorrhea

treatment Unilateral salpingo-oophorectomy Chemotherapy- not effective 5 year survival rate: 70-90%

Fallopian Tube Cancer Extremely rare: 0.5% of genital tract cancers 80-90% of FT malignancies are metastatic from other sites (ovary, uterus, GIT Unknown etiology Hereditary association (BRCA1)

Clinical manifestation Hydrops tubae profluens: profuse watery discharge, pelvic pain and pelvic mass - Classic triad of fallopian Ca, only 15% of cases, pathognomonic

Treatment TAHBSO, retriperitoneal lymph node sampling Carboplatin and paclitaxel- adjunct therapy